|
PLS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.050000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.294600E-01 |
| Normal-vs-Stage2 |
4.846200E-02 |
| Normal-vs-Stage3 |
8.503200E-01 |
| Normal-vs-Stage4 |
5.823000E-01 |
| Stage1-vs-Stage2 |
6.112400E-02 |
| Stage1-vs-Stage3 |
9.947200E-01 |
| Stage1-vs-Stage4 |
4.353000E-01 |
| Stage2-vs-Stage3 |
7.740300E-02 |
| Stage2-vs-Stage4 |
3.870100E-02 |
| Stage3-vs-Stage4 |
4.719200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.049400E-01 |
| Normal-vs-AfricanAmerican |
5.676200E-01 |
| Normal-vs-Asian |
7.091800E-01 |
| Caucasian-vs-AfricanAmerican |
5.020200E-01 |
| Caucasian-vs-Asian |
5.949400E-01 |
| AfricanAmerican-vs-Asian |
8.364400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.842430E-01 |
| Normal-vs-Female |
9.423600E-01 |
| Male-vs-Female |
8.491600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.822200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.309800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.046000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.298200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.438200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.186400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.446980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.542400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.104800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.454000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.344600E-01 |
| Classical-VS-Follicular |
1.56039958731924E-10 |
| Classical-VS-Other |
5.802000E-01 |
| Classical-VS-Normal |
2.706400E-01 |
| Tall-VS-Follicular |
7.83630000000812E-05 |
| Tall-VS-Other |
5.488000E-01 |
| Tall-VS-Normal |
5.330200E-01 |
| Follicular-VS-Other |
1.200010E-01 |
| Follicular-VS-Normal |
8.20990000000021E-05 |
| Other-VS-Normal |
7.901400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.342500E-02 |
| Normal-vs-N1 |
9.638600E-01 |
| N0-vs-N1 |
1.301630E-01 |
|
|
